Cancer Research Meeting Calendar Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Cancer Research 67, 3994, May 1, 2007. doi: 10.1158/0008-5472.CAN-07-0525
© 2007 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Noren, N. K.
Right arrow Articles by Pasquale, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noren, N. K.
Right arrow Articles by Pasquale, E. B.
Related Collections
Right arrow Cellular Pathobiology: Proliferation, Senescence, and Death
Right arrow Tumor Biology
Right arrow Tumor Biology: Invasion and Metastasis

Reviews

Paradoxes of the EphB4 Receptor in Cancer

Nicole K. Noren1 and Elena B. Pasquale1,2

1 Burnham Institute for Medical Research and 2 Pathology Department, University of California San Diego, La Jolla, California

Requests for reprints: Elena B. Pasquale, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037. Phone: 858-646-3131; Fax: 858-646-3199; E-mail: elenap{at}burnham.org.

Recent findings have started to uncover the intriguing roles of the Eph family of receptor tyrosine kinases in normal epithelial cells and during oncogenic transformation. This review focuses on EphB4, an Eph receptor that has both tumor-suppressing and tumor-promoting activities in breast cancer. Understanding the multifaceted role of EphB4 in tumorigenesis may allow the development of new anticancer therapies. [Cancer Res 2007;67(9):3994–7]




This article has been cited by other articles:


Home page
 Mol Cancer ResHome page
J. Wykosky and W. Debinski
The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
Mol. Cancer Res., December 1, 2008; 6(12): 1795 - 1806.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Noberini, M. Koolpe, S. Peddibhotla, R. Dahl, Y. Su, N. D. P. Cosford, G. P. Roth, and E. B. Pasquale
Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors
J. Biol. Chem., October 24, 2008; 283(43): 29461 - 29472.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
M. Lackmann and A. W. Boyd
Eph, a Protein Family Coming of Age: More Confusion, Insight, or Complexity?
Sci. Signal., April 15, 2008; 1(15): re2 - re2.
[Abstract] [Full Text] [PDF]

Home page
 CRO ContentHome page
G. C. Prendergast
Biological research in cancer: Convergent versus divergent problems
Cancer Reviews Online Content, June 1, 2007; 2007(3): 5 - 6.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.